» Articles » PMID: 29036664

Trigger Point Diagnosis: At Last, the First Word on Consensus

Overview
Journal Pain Med
Date 2017 Oct 17
PMID 29036664
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Latent myofascial trigger points injection therapy for adult cough variant asthma: A randomized controlled trial.

Liu Q, Zhang W, Tian T, Liu Y, Bai H, Hu Q Front Med (Lausanne). 2023; 10:937377.

PMID: 36910483 PMC: 9995510. DOI: 10.3389/fmed.2023.937377.


Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger points TNF-α/ NF-κB signaling pathway in rats.

Liu M, Liu Y, Li X, Pei M, Han M, Qi F Front Pharmacol. 2022; 13:1031804.

PMID: 36408215 PMC: 9669483. DOI: 10.3389/fphar.2022.1031804.


Peripheral EphrinB1/EphB1 signalling attenuates muscle hyperalgesia in MPS patients and a rat model of taut band-associated persistent muscle pain.

Jin F, Zhao L, Hu Q, Qi F Mol Pain. 2020; 16:1744806920984079.

PMID: 33356837 PMC: 7780166. DOI: 10.1177/1744806920984079.


The pathophysiological nature of sarcomeres in trigger points in patients with myofascial pain syndrome: A preliminary study.

Jin F, Guo Y, Wang Z, Badughaish A, Pan X, Zhang L Eur J Pain. 2020; 24(10):1968-1978.

PMID: 32841448 PMC: 7693045. DOI: 10.1002/ejp.1647.


Soft Tissue and Trigger Point Release, Second Edition.

Balletto J Int J Ther Massage Bodywork. 2019; 12(2):31-32.

PMID: 31191787 PMC: 6542575.